Meta-Analysis of Randomized Controlled Trials on Androgens versus Erythropoietin for Anaemia of Chronic Kidney Disease: Implications for Developing Countries
Androgens which are relatively cheap were used in the treatment of anaemia in dialysis patients before the advent of Erythropoietin (EPO). However, there are concerns about their efficacy and side effects. Aims. To examine the efficacy and harms of androgens for the treatment of anaemia of chronic k...
Main Authors: | Adamu, B., Ma'aji, S. M., Erwin, P. J., Tleyjeh, I. M. |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479968/ |
Similar Items
-
Financial distress among SMES in Malaysia: An early warning signal
by: Ma'aji, Muhammad Muhammad
Published: (2014) -
Erythropoietin, uncertainty principle and cancer related anaemia
by: Clark, Otavio, et al.
Published: (2002) -
Management of anaemia in CKD—the relative importance of erythropoietin and iron
by: Agarwal, Rajiv
Published: (2011) -
Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
by: Barosi, G., et al.
Published: (1998) -
Efficacy & safety of continuous erythropoietin receptor activator (CERA) in treating renal anaemia in diabetic patients with chronic kidney disease not on dialysis
by: Vankar, Sameer G., et al.
Published: (2014)